TY - JOUR
T1 - Standardized numbering and alignment of the KPC family of β-lactamases
AU - Brunetti, Florencia
AU - Marshall, Steven H.
AU - Bethel, Christopher R.
AU - Hujer, Andrea M.
AU - Hujer, Kristine M.
AU - Haider, Shozeb
AU - Bush, Karen
AU - Bradford, Patricia A.
AU - Kreiswirth, Barry
AU - Spencer, James
AU - Ishii, Yoshikazu
AU - Docquier, Jean Denis
AU - Rossolini, Gian Maria
AU - Poirel, Laurent
AU - Perilli, Mariagrazia
AU - Amicosante, Gianfranco
AU - Galleni, Moreno
AU - Vila, Alejandro J.
AU - Gutkind, Gabriel
AU - Palzkill, Timothy
AU - Carattoli, Alessandra
AU - Tooke, Catherine L.
AU - Hinchliffe, Philip
AU - Schofield, Christopher J.
AU - Iorga, Bogdan I.
AU - Naas, Thierry
AU - Chen, Yu
AU - Arias, Cesar
AU - Endimiani, Andrea
AU - Papp-Wallace, Krisztina
AU - Shields, Ryan K.
AU - Tamma, Pranita D.
AU - Bonomo, Robert A.
AU - Power, Pablo
N1 - Publisher Copyright:
Copyright © 2026 Brunetti et al.
PY - 2026/7
Y1 - 2026/7
N2 - The KPC family of serine β-lactamases comprises more than 260 members. Some variants are associated with ceftazidime-avibactam resistance in clinical isolates, often linked to substitutions and/or insertions/deletions (i.e., INDELs) in three distinct loops of the KPC sequence: (i) the 164–179 loop (i.e., the Ω loop); (ii) the 237–243 loop; and (iii) the 267–275 loop. Inconsistencies in residue numbering across published reports, however, complicate the accurate annotation of KPC variants. We retrieved 267 KPC variant sequences from the Beta-Lactamase Database (BLDB) in September 2025 and analyzed sequence differences between variants using combined nucleotide and structure-guided alignment algorithms, supported by AlphaFold3 modeling in ambiguous cases. Variants were classified into four groups to comprehensively review sequence changes across the KPC family: substitutions only (n = 126), deletions only (n = 17), insertions only (n = 66), and variants with two or more types of amino acid changes (n = 57). Comparisons with previous reports indicate that many annotation errors stem from overlooking the absent residues 58 and 253 in the KPC consensus sequence, and that most inconsistencies in annotation and residue assignment occur in INDEL variants. To address these issues, we propose a standardized annotation scheme for substitutions, deletions, and insertions for the KPC family, based on the Ambler numbering system, and supported by structural information. This systematic scheme will help to standardize the description of newly emerging KPC variants and prevent discrepancies in future reports in the context of antimicrobial resistance.
AB - The KPC family of serine β-lactamases comprises more than 260 members. Some variants are associated with ceftazidime-avibactam resistance in clinical isolates, often linked to substitutions and/or insertions/deletions (i.e., INDELs) in three distinct loops of the KPC sequence: (i) the 164–179 loop (i.e., the Ω loop); (ii) the 237–243 loop; and (iii) the 267–275 loop. Inconsistencies in residue numbering across published reports, however, complicate the accurate annotation of KPC variants. We retrieved 267 KPC variant sequences from the Beta-Lactamase Database (BLDB) in September 2025 and analyzed sequence differences between variants using combined nucleotide and structure-guided alignment algorithms, supported by AlphaFold3 modeling in ambiguous cases. Variants were classified into four groups to comprehensively review sequence changes across the KPC family: substitutions only (n = 126), deletions only (n = 17), insertions only (n = 66), and variants with two or more types of amino acid changes (n = 57). Comparisons with previous reports indicate that many annotation errors stem from overlooking the absent residues 58 and 253 in the KPC consensus sequence, and that most inconsistencies in annotation and residue assignment occur in INDEL variants. To address these issues, we propose a standardized annotation scheme for substitutions, deletions, and insertions for the KPC family, based on the Ambler numbering system, and supported by structural information. This systematic scheme will help to standardize the description of newly emerging KPC variants and prevent discrepancies in future reports in the context of antimicrobial resistance.
KW - KPC INDEL variants
KW - KPC carbapenemase
KW - KPC variants
KW - beta-lactamase nomenclature
UR - https://www.scopus.com/pages/publications/105043689934
UR - https://www.scopus.com/inward/citedby.url?scp=105043689934&partnerID=8YFLogxK
U2 - 10.1128/aac.01868-25
DO - 10.1128/aac.01868-25
M3 - Article
C2 - 42210696
AN - SCOPUS:105043689934
SN - 0066-4804
VL - 70
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 7
M1 - e01868-25
ER -